Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea.
CEO Office, Institut Pasteur Korea, Seongnam, Korea.
J Med Virol. 2021 Mar;93(3):1403-1408. doi: 10.1002/jmv.26397. Epub 2020 Aug 16.
Drug repositioning represents an effective way to control the current COVID-19 pandemic. Previously, we identified 24 FDA-approved drugs which exhibited substantial antiviral effect against severe acute respiratory syndrome coronavirus 2 in Vero cells. Since antiviral efficacy could be altered in different cell lines, we developed an antiviral screening assay with human lung cells, which is more appropriate than Vero cell. The comparative analysis of antiviral activities revealed that nafamostat is the most potent drug in human lung cells (IC = 0.0022 µM).
药物重定位是控制当前 COVID-19 大流行的有效方法。此前，我们在 Vero 细胞中鉴定出 24 种对严重急性呼吸综合征冠状病毒 2 具有显著抗病毒作用的 FDA 批准药物。由于抗病毒功效在不同细胞系中可能发生变化，因此我们开发了一种使用人肺细胞的抗病毒筛选测定法，比 Vero 细胞更合适。抗病毒活性的比较分析表明，那法莫司他是在人肺细胞中最有效的药物（IC = 0.0022 µM）。
